Search results
Moderna Employees Should Use ChatGPT at Least 20 Times a Day, CEO Says
Gizmodo via Yahoo News· 53 minutes agoStéphane Bancel, CEO of Moderna at the Fast Company Innovation Festival on September 21, 2023 in New...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 4 hours agoModerna (MRNA) doesn't possess the right combination of the two key ingredients for a likely...
At Moderna, OpenAI’s GPTs Are Changing Almost Everything
The Wall Street Journal· 1 day agoModerna is expected to announce a partnership Wednesday with artificial-intelligence heavyweight...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 23 hours agoModerna stock is yo-yoing after the company unveiled early-stage test results for its...
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 13 hours agoCerity Partners LLC increased its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 106.6% during the 4th quarter, according to the company in its most recent ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 2 weeks agoIn a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Finance· 4 days agoIn the last year, many Moderna, Inc. (NASDAQ:MRNA) insiders sold a substantial stake in the company...
Moderna turns to AI to change how its employees work
CIO Dive· 7 hours agoModerna is betting big on bespoke artificial intelligence assistants. The biotechnology company on Wednesday said it has expanded a partnership with OpenAI, the buzzy creator ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 31 minutes agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...